<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Syndecan-1 is a transmembrane heparansulfate <z:chebi fb="0" ids="37396">proteoglycan</z:chebi>, which regulates cell proliferation, migration, <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, cell-to-cell and cell-to-extracellular matrix <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and may influence malignant cell behavior </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the alterations of syndecan-1 expression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and analyzed the relationship between clinicopathological parameters, proliferation indices, angiogenic markers, and extracellular matrix components </plain></SENT>
<SENT sid="2" pm="."><plain>Syndecan-1 protein expression observed in the tumorous epithelium was high in 52/97 (53.6%) of the studied cases, moderate in 20/97 (20.6%), and weak in 5/97 (5.22%) of the cases, and there was strong stromal expression in 34.02% of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Syndecan-1 expression was statistically correlated to VEGF expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> (p=0.001) and vessels (p=0.007) </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, there was a borderline correlation between syndecan-1 expression and tenascin (p=0.053) </plain></SENT>
<SENT sid="5" pm="."><plain>Patients with weak staining reaction had a more unfavorable prognosis (p=0.032) in univariate analysis </plain></SENT>
<SENT sid="6" pm="."><plain>These results indicate the implication of syndecan-1 in the remodeling and <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissue, through interaction with other extracellular matrix components and VEGF, probably influencing the <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> and <z:hpo ids='HP_0000718'>aggressiveness</z:hpo> </plain></SENT>
</text></document>